Last 12 months
Inside the activity.
5 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 24, 2017 Filed May 26, 2017 20:50 UTC |
EDELMAN RICHARD WDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 11,621 | $0.00 Strike: $13.16 | $0.00 |
DisclosureSEC source: 0001179110-17-008141 · edgar.xml · derivative · entry 5 EDELMAN RICHARD W · CIK 0001184931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,379 Underlying: Common Stock · 11,621 shares Expires 2017-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Became exercisable in equal annual installments of 20% commencing 06/25/2011. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:50 UTC |
EDELMAN RICHARD WDirector
|
SaleCommon Stock, No Par Value | 7,437 | $34.50 | $256,576.50 |
DisclosureSEC source: 0001179110-17-008141 · edgar.xml · nonDerivative · entry 2 EDELMAN RICHARD W · CIK 0001184931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,184 F1 · date: The Reporting Person ceased to be a director of the Issuer on March 24, 2017. F2 · shares: The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 7,437 of such shares to pay the exercise price and taxes and issuing the remaining 4,184 shares to the Reporting Person. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:50 UTC |
EDELMAN RICHARD WDirector
|
Exercise / conversionCommon Stock, No Par Value | 11,621 | $13.16 | $152,932.36 |
DisclosureSEC source: 0001179110-17-008141 · edgar.xml · nonDerivative · entry 1 EDELMAN RICHARD W · CIK 0001184931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: The Reporting Person ceased to be a director of the Issuer on March 24, 2017. F2 · shares: The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 7,437 of such shares to pay the exercise price and taxes and issuing the remaining 4,184 shares to the Reporting Person. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:47 UTC |
Miller Franklin JDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $34.40 | $0.00 |
DisclosureSEC source: 0001179110-17-008138 · edgar.xml · derivative · entry 9 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-05-24 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:47 UTC |
STILLABOWER MICHAEL EDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $34.40 | $0.00 |
DisclosureSEC source: 0001179110-17-008137 · edgar.xml · derivative · entry 8 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-05-24 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:47 UTC |
Karras Nolan E.Director
|
GrantNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $34.40 | $0.00 |
DisclosureSEC source: 0001179110-17-008136 · edgar.xml · derivative · entry 8 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-05-24 F6 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/24/2018. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:46 UTC |
Millner F. Ann Ed.D.Director
|
GrantNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $34.40 | $0.00 |
DisclosureSEC source: 0001179110-17-008135 · edgar.xml · derivative · entry 3 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-05-24 F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/24/2018. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:46 UTC |
STANGER KENT WDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $34.40 | $0.00 |
DisclosureSEC source: 0001179110-17-008134 · edgar.xml · derivative · entry 9 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-05-24 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 05/24/2018. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:46 UTC |
ANDERSON A SCOTTDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $34.40 | $0.00 |
DisclosureSEC source: 0001179110-17-008132 · edgar.xml · derivative · entry 7 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-05-24 F6 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018. Read SEC document |
| May 19, 2017 Filed May 19, 2017 23:01 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.16 | $0.00 |
DisclosureSEC source: 0001179110-17-007645 · edgar.xml · derivative · entry 3 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2017-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/25/2011. Read SEC document |
| May 19, 2017 Filed May 19, 2017 23:01 UTC |
STILLABOWER MICHAEL EDirector
|
SaleCommon Stock, No Par Value | 17,110 | $33.71 | $576,798.63 |
DisclosureSEC source: 0001179110-17-007645 · edgar.xml · nonDerivative · entry 2 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,668 F1 · shares: The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 17,110 of such shares to pay the exercise price and taxes and issuing the remaining 7,890 shares to the Reporting Person. F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.675 to 33.75, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 19, 2017 Filed May 19, 2017 23:01 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionCommon Stock, No Par Value | 25,000 | $13.16 | $329,000.00 |
DisclosureSEC source: 0001179110-17-007645 · edgar.xml · nonDerivative · entry 1 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 17,110 of such shares to pay the exercise price and taxes and issuing the remaining 7,890 shares to the Reporting Person. Read SEC document |
| May 15, 2017 Filed May 16, 2017 21:52 UTC |
Miller Franklin JDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.16 | $0.00 |
DisclosureSEC source: 0001179110-17-007330 · edgar.xml · derivative · entry 4 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2017-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/25/2011. Read SEC document |
| May 15, 2017 Filed May 16, 2017 21:52 UTC |
Miller Franklin JDirector
|
SaleCommon Stock, No Par Value | 16,090 | $33.95 | $546,289.29 |
DisclosureSEC source: 0001179110-17-007330 · edgar.xml · nonDerivative · entry 3 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,244 F8 · shares: The reporting person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 16,090 of such shares to pay the exercise price and taxes and issuing the remaining 8,910 shares to the reporting person. F9 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.90 to $34.03, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 15, 2017 Filed May 16, 2017 21:52 UTC |
Miller Franklin JDirector
|
Exercise / conversionCommon Stock, No Par Value | 25,000 | $13.16 | $329,000.00 |
DisclosureSEC source: 0001179110-17-007330 · edgar.xml · nonDerivative · entry 2 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · shares: The reporting person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 16,090 of such shares to pay the exercise price and taxes and issuing the remaining 8,910 shares to the reporting person. Read SEC document |
| April 14, 2017 Filed Apr 18, 2017 23:10 UTC |
Lloyd Brian G.Chief Legal Officer, Secretary
|
GrantNon-qualified stock options (right to buy) · Derivative | 50,000 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001179110-17-006050 · edgar.xml · derivative · entry 2 Lloyd Brian G. · CIK 0001671772 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-04-14 F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018. Read SEC document |
| April 14, 2017 Filed Apr 18, 2017 23:17 UTC |
Birkett BernardChief Financial Officer
|
GrantNon-qualified stock options (right to buy) · Derivative | 50,000 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001179110-17-006054 · edgar.xml · derivative · entry 6 Birkett Bernard · CIK 0001658001 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-04-14 F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 04/14/18. Read SEC document |
| April 14, 2017 Filed Apr 18, 2017 23:17 UTC |
Lampropoulos Fred P.Director · President & CEO
|
GrantNon-qualified stock options (right to buy) · Derivative | 10,000 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001179110-17-006053 · edgar.xml · derivative · entry 12 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Please refer to footnote number five. Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-04-14 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 4/14/2018. F5 · ownership.nature: Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| April 14, 2017 Filed Apr 18, 2017 23:17 UTC |
Lampropoulos Fred P.Director · President & CEO
|
GrantNon-qualified stock options (right to buy) · Derivative | 200,000 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001179110-17-006053 · edgar.xml · derivative · entry 11 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-04-14 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 4/14/2018. Read SEC document |
| April 14, 2017 Filed Apr 18, 2017 23:12 UTC |
Lampropoulos Justin J.EXEC. V.P. MKTG & STRATEGY
|
GrantNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001179110-17-006052 · edgar.xml · derivative · entry 6 Lampropoulos Justin J. · CIK 0001643609 · EXEC. V.P. MKTG & STRATEGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-04-14 F6 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018. Read SEC document |
| April 14, 2017 Filed Apr 18, 2017 23:11 UTC |
Wright JosephPresident, International
|
GrantNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001179110-17-006051 · edgar.xml · derivative · entry 6 Wright Joseph · CIK 0001643713 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-04-14 F6 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018. Read SEC document |
| April 14, 2017 Filed Apr 18, 2017 23:10 UTC |
Frost RonaldChief Operating Officer
|
GrantNon-qualified stock options (right to buy) · Derivative | 50,000 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001179110-17-006049 · edgar.xml · derivative · entry 6 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-04-14 F6 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing 04/14/2018. Read SEC document |
| December 30, 2016 Filed Feb 1, 2017 20:51 UTC |
STANGER KENT WDirector
|
GiftCommon Stock, No Par Value | 2,812 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-001436 · edgar.xml · nonDerivative · entry 4 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,534 F4 · price: This is a gift. Read SEC document |
| December 09, 2016 Filed Dec 12, 2016 20:35 UTC |
STANGER KENT WDirector
|
SaleCommon Stock, No Par Value | 8,000 | $26.42 | $211,328.00 |
DisclosureSEC source: 0001179110-16-032793 · edgar.xml · nonDerivative · entry 5 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,346 F5 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.25 to $26.75, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 22:37 UTC |
Frost RonaldChief Operating Officer
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 15,000 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-16-032880 · edgar.xml · derivative · entry 4 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing 08/11/2012. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 22:37 UTC |
Frost RonaldChief Operating Officer
|
SaleCommon Stock, No Par Value | 15,000 | $26.25 | $393,750.00 |
DisclosureSEC source: 0001179110-16-032880 · edgar.xml · nonDerivative · entry 3 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 22:37 UTC |
Frost RonaldChief Operating Officer
|
Exercise / conversionCommon Stock, No Par Value | 15,000 | $13.75 | $206,250.00 |
DisclosureSEC source: 0001179110-16-032880 · edgar.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2016 Filed Dec 12, 2016 20:35 UTC |
STANGER KENT WDirector
|
SaleCommon Stock, No Par Value | 4,000 | $25.98 | $103,917.60 |
DisclosureSEC source: 0001179110-16-032793 · edgar.xml · nonDerivative · entry 4 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,346 F4 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.90 to $26.025, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:01 UTC |
Lampropoulos Fred P.Director · President & CEO
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.82 | $0.00 |
DisclosureSEC source: 0001179110-16-029673 · edgar.xml · derivative · entry 6 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2016-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 9/26/2010. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:01 UTC |
Lampropoulos Fred P.Director · President & CEO
|
Tax withholdingCommon Stock, No Par Value | 17,628 | $24.50 | $431,886.00 |
DisclosureSEC source: 0001179110-16-029673 · edgar.xml · nonDerivative · entry 5 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,070,869 F8 · kind: Stock options were exercised in a swap transaction with the Company. 17,628 shares of common stock were surrendered in payment of the option exercise price and assorted payroll tax liability. No shares were sold in the open market. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:01 UTC |
Lampropoulos Fred P.Director · President & CEO
|
Exercise / conversionCommon Stock, No Par Value | 25,000 | $13.82 | $345,500.00 |
DisclosureSEC source: 0001179110-16-029673 · edgar.xml · nonDerivative · entry 4 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,088,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · kind: Stock options were exercised in a swap transaction with the Company. 17,628 shares of common stock were surrendered in payment of the option exercise price and assorted payroll tax liability. No shares were sold in the open market. Read SEC document |
| October 04, 2014 Filed May 22, 2020 21:51 UTC Amendment |
Lampropoulos Fred P.Director · PRESIDENT AND CEO
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001415889-20-001318 · form4a-05222020_020512.xml · derivative · entry 1 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,000 Underlying: Common Stock · Not disclosed shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 10/4/2015. F2 · balance_after: On October 7, 2014, the reporting person filed a Form 4 which omitted a grant of non-qualified stock options to his spouse. This Amended Form 4 is being filed to correct that omission. F3 · ownership.nature: Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| August 11, 2011 Filed Jun 6, 2018 20:44 UTC Amendment |
Lampropoulos Fred P.Director · President & CEO
|
GrantNon-qualified stock options (right to buy) · Derivative | 2,500 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-18-008153 · edgar.xml · derivative · entry 20 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Please refer to footnote number ten (10). Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2018-08-11 F9 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 8/11/2012. F10 · ownership.nature: This Amendment is filed to report the granting of stock options to the reporting person's spouse. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| August 11, 2011 Filed Jun 6, 2018 20:44 UTC Amendment |
Lampropoulos Fred P.Director · President & CEO
|
GrantNon-qualified stock options (right to buy) · Derivative | 120,000 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-18-008153 · edgar.xml · derivative · entry 19 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2018-08-11 F9 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 8/11/2012. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.